NCT04126681 2025-03-03A Pivotal Study of HQP1351 in Patients With Chronic Myeloid Leukemia in Chronic PhaseAscentage Pharma Group Inc.Phase 2 Completed144 enrolled
NCT00114959 2015-01-15Homoharringtonine With Oral Gleevec in Chronic, Accelerated and Blast Phase Chronic Myeloid Leukemia (CML)Teva Branded Pharmaceutical Products R&D, Inc.Phase 2 Terminated15 enrolled 6 charts